Table 2.
Nitrotyrosine Immunoreactivity in Multiple Sclerosis Tissue
| Case no. | Age/sex | Sections examined and diagnosis | Nitrotyrosine reactivity* | Regional localization |
|---|---|---|---|---|
| 1 | 54 /F | 5, Balo’s concentric sclerosis | 4+ | Lesion center and perilesional white matter |
| 2, NAWM | None | |||
| 2 | 31 /F | 2, Acute MS | 3+ | Lesion center |
| 12 | 34 /F | 5, Acute MS | 2+ | Lesion center & perilesional white matter |
| 11 | 33 /F | 4, Chronic active MS | + | Perilesional white matter |
| 4 | 55 /F | 4, Chronic silent MS | ± | Lesion edge |
| 1, NAWM | None | |||
| 13 | 71 /F | 2, Chronic silent MS | None | |
| 14 | 46 /M | 4, Chronic silent MS | ± | Perilesional white matter |
| 1, NAWM | None | |||
| 9 | 41 /M | 2, Normal | None | |
| 10 | 35 /F | 2, Normal | None |
*Nitrotyrosine immunoreactivity was assessed using an arbitrary scale of 0 to 4.
NAWM: normal-appearing white matter.